Interestingly, it also shows significant preclinical antitumor activity by triggering apoptosis in vitro and suppressing tumor formation in vivo via the PTP activity of SHP-1 that negatively targets p-STAT3Tyr705 signals in various cancer types [10–13]. This evidence concerns the gene PTPN6 and cancer.